Article Versions Notes

Khan H, Makwana V, Santos SNd, Bonacossa de Almeida CE, Santos-Oliveira R, Missailidis S. Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy. Pharmaceutics. 2021; 13(8):1239. https://doi.org/10.3390/pharmaceutics13081239

Khan, Huma, Vaidehi Makwana, Sofia Nascimento dos Santos, Carlos Eduardo Bonacossa de Almeida, Ralph Santos-Oliveira, and Sotiris Missailidis. 2021. "Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy" Pharmaceutics 13, no. 8: 1239. https://doi.org/10.3390/pharmaceutics13081239

Khan, H., Makwana, V., Santos, S. N. d., Bonacossa de Almeida, C. E., Santos-Oliveira, R., & Missailidis, S. (2021). Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy. Pharmaceutics, 13(8), 1239. https://doi.org/10.3390/pharmaceutics13081239